This Genes and Disease page has been moved to:
http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowSection&rid=gnd.section.218

Please update your bookmarks.

If you are not automatically transported to the new page after 15 seconds, click on this link

.
Genes and disease header bar


newGenome View

SCA1
on chromosome 6
Databases

PubMed
the literature
LocusLink
collection of gene-related information
OMIM
catalog of human genes and disorders

Information

Fact sheet
from the National Institute of Neurological Disorders and Stroke, NIH

The National Ataxia Foundation
supporting research into hereditary ataxia

GeneClinics
a medical genetics resource


PERSONS WITH spinocerebellar atrophy, of which there are several types, experience a degeneration of the spinal cord and the cerebellum, the small fissured mass at the base of the brain, behind the brain stem. The cerebellum is concerned with coordination of movements, so atrophy or "wasting away" of this critical control center results in a loss of muscle coordination. Atrophy in the spine can bring spasticity.
  The basic defect in all types of spinocerebellar atrophy is a an expansion of a CAG triplet repeat. In this way, it is similar to fragile-X syndrome, Huntington disease and myotonic dystrophy, all of which exhibit a triplet repeat expansion of a gene. In the case of spinocerebellar atrophy I, the gene is SCA1, found on chromosome 6. The protein product of the gene - called ataxin-1 - varies in size, depending on the size of the CAG triplet repeat.
  A homolog of human ataxin-1 has been found in mice, where it is found on chromosome 13 instead of chromosome 6. The two proteins are highly similar, except that in the mouse, the poly-glutamine tract (coded for by the CAG repeat ) is missing, suggesting that it is not essential for normal function in mice.